Medication for High Testosterone in Women
For women with elevated testosterone levels, oral contraceptives are the first-line pharmacological treatment, with the addition of an antiandrogen (such as spironolactone) after 6 months if response is inadequate 1.
Initial Diagnostic Approach
Before initiating treatment, determine the underlying cause:
- Test for elevated androgens if hirsutism is moderate-to-severe (score >15), sudden onset, rapidly progressive, or accompanied by virilization signs (clitoromegaly, increased muscularity), menstrual irregularities, or obesity 1
- Measure testosterone in early morning (days 4-10 of menstrual cycle in regularly cycling women) for accurate assessment 1
- Rule out androgen-secreting tumors if testosterone is very high (>2-3 SD above normal), especially with rapid progression or virilization 1, 2
- Discontinue androgenic medications if applicable (anabolic steroids, valproic acid) 1
Pharmacological Treatment Algorithm
First-Line: Oral Contraceptives
Oral contraceptive pills (OCPs) should be initiated as monotherapy for most women with elevated testosterone 1. OCPs work by:
- Suppressing LH and reducing ovarian androgen production
- Increasing sex hormone-binding globulin (SHBG), which reduces free testosterone
- Normalizing testosterone levels within 12-16 weeks 3
Low-dose estrogen formulations (30 mcg ethinyl estradiol) are effective and minimize side effects 3.
Second-Line: Add Antiandrogen
If response to OCPs alone is suboptimal after 6 months, add an antiandrogen 1:
- Spironolactone is the preferred antiandrogen (ranked highly in recent meta-analysis) 4
- Spironolactone + metformin combination ranked first for reducing total testosterone in PCOS patients (SUCRA 85.0%) 4
- Cyproterone acetate is an alternative where available 5
Critical Safety Warning
Antiandrogens must NEVER be used as monotherapy in women of reproductive potential without adequate contraception due to teratogenic risk 1. This is a strong recommendation (Grade 1) from the Endocrine Society.
Alternative Options for Specific Populations
For women who cannot or choose not to use OCPs:
- Antiandrogens alone (with reliable contraception) 1
- Atorvastatin showed promise in recent network meta-analysis (ranked first for free testosterone reduction, SUCRA 75.0%) 4, though this is off-label use
What NOT to Use
- Avoid flutamide due to hepatotoxicity risk 1
- Insulin-sensitizing drugs (metformin) as monotherapy are not recommended for testosterone reduction alone 1, though they may be added to spironolactone for enhanced effect 4
Common Pitfalls to Avoid
- Don't miss androgen-secreting tumors: Very high testosterone (>2-3 SD above normal) without virilization can still indicate tumor; imaging may be needed 2
- Laboratory interference: If testosterone levels seem discordant with clinical picture, consider diethyl-ether extraction to rule out assay interference 2
- Inadequate contraception: The teratogenic potential of antiandrogens cannot be overstated—ensure reliable contraception before prescribing 1
- Premature discontinuation: Clinical improvement in hirsutism takes 12-16 weeks; counsel patients on realistic timelines 3